Dairy farmer and farm staff attitudes and perceptions regarding daily milk allowance to calves by C. Svensson, A.-L. Hegrestad, J. Lindblom

Get full text

Maternal substance use disorder predicting children's emotion regulation in middle childhood: the role of early mother-infant interaction by R.-L. Punamäki, M. Flykt, R. Belt, J. Lindblom

Get full text

PO.2.27 Early changes in the circulating B cell compartment associated with response to treatment and occurrence of flares in patients receiving therapy for active systemic lupus e... by A Doria, J Lindblom, I Parodis, M Gatto, A Gomez Gonzales

S06.1 B cell kinetics upon therapy commencement for active extra-renal systemic lupus erythematosus in relation to development of renal flares by A Gómez, J Lindblom, I Parodis, C Sjöwall, M Gatto, S Sciascia, JW Chow

Early pathways of maternal mentalization: Associations with child development in the FinnBrain birth cohort study by J. Lindblom, J. Lindblom, M. Pajulo, M. Pajulo, S. Nolvi, S. Nolvi, S. Nolvi, K. Tervahartiala, K. Tervahartiala, H. Karlsson, H. Karlsson, H. Karlsson, L. Karlsson, L. Karlsson, L. Karlsson, R. Korja, R. Korja

Get full text

PO.7.146 Sensitivity analysis of EQ-5D-3L index scores in relation to discriminative and known-groups validity in systemic lupus erythematosus by A Gómez, J Lindblom, I Parodis, N Hua, G Von Perner, Y Enman, M Regardt, E Heintz, S Emamikia, D Grannas

PO.1.21 Attainment of EQ-5D-3L full health state after therapy is associated with decelerated organ damage accrual in systemic lupus erythematosus by A Borg, A Gómez, J Lindblom, I Parodis, G Von Perner, Y Enman, M Regardt, E Heintz, S Emamikia, D Grannas, S Zetterberg

PO.7.149 Associations between abnormal bmi and patient-reported health-related quality of life before and after therapeutic intervention in patients with systemic lupus erythematos... by A Borg, A Gómez, J Lindblom, I Parodis, A Soltani, G Von Perner, Y Enman, M Regardt, E Heintz, S Emamikia, D Grannas

PO.5.99 Drug repurposing for treating lupus nephritis based on transcriptome profiling and autoimmunity-related serological markers by J Lindblom, MO Borghi, M Alarcón-Riquelme, C Mohan, J Castillo, G Barturen, I Parodis, Y Enman, E Carnero-Montoro, D Toro-Domínguez, D Repsilber

PO.1.12 Transcriptome profiling and autoimmunity-related serological markers identify TP53 and C3aR as drug targets in neuropsychiatric systemic lupus erythematosus by J Lindblom, MO Borghi, M Alarcón-Riquelme, C Mohan, J Castillo, G Barturen, I Parodis, E Iacobaeus, Y Enman, E Carnero-Montoro, D Toro-Domínguez, D Repsilber